Market Expert Sudip Bandyopadhyay Offers Investment Insights Amid Economic Uncertainty
Buy capital goods on dips, stay cautious on IT and consumption: Sudip Bandyopadhyay
The Economic TimesImage: The Economic Times
Sudip Bandyopadhyay, a market expert, suggests buying capital goods during price dips while remaining cautious about IT and consumer sectors. He highlights the strong fundamentals of State Bank of India and the growth potential in the pharma sector, particularly with Sun Pharma's strategic acquisition.
- 01State Bank of India shows strong fundamentals despite recent selloff.
- 02Indian pharma sector poised for long-term growth, led by Sun Pharma's acquisition.
- 03Caution advised in consumer sector due to potential monsoon risks.
- 04Capital goods are recommended for long-term investment during price dips.
- 05Selective investment in IT is favored until clearer market conditions emerge.
Advertisement
In-Article Ad
Market expert Sudip Bandyopadhyay emphasizes the importance of strategic investments in the current economic climate. He views the recent selloff of State Bank of India as a profit-booking move rather than a reflection of its health, citing a 16% credit growth and a 3% net interest margin as indicators of stability. Bandyopadhyay believes the Indian pharma sector is entering a multi-decade growth phase, particularly following Sun Pharma's acquisition of Organon, which enhances its branded product portfolio. In contrast, he urges caution in the consumer sector, primarily due to potential risks from the El Niño-related monsoon, suggesting a focus on large-cap FMCG companies like HUL and Nestle. He expresses strong conviction in capital goods, advising investors to seize opportunities during price dips in quality stocks such as L&T, BHEL, and Thermax. For the IT sector, he recommends a selective approach, focusing on companies like HCL Technologies and Coforge, while waiting for more favorable valuation conditions.
Advertisement
In-Article Ad
Investors may find opportunities in capital goods and pharma sectors, potentially leading to long-term portfolio growth. However, caution in consumer spending could affect rural demand, impacting businesses reliant on this sector.
Advertisement
In-Article Ad
Reader Poll
What sector do you believe offers the best investment opportunities right now?
Connecting to poll...
More about State Bank of India

Analyzing PSU Bank Stocks Post Q4 FY26 Earnings: SBI, PNB, or BoB?
Mint • May 9, 2026
Earnings Reports from 33 Companies Including Blue Dart and Birla Corp Scheduled for May 9
Business Standard • May 9, 2026
State Bank of India Shares Plunge Nearly 7% Following Disappointing Q4 Earnings
The Economic Times • May 9, 2026
Read the original article
Visit the source for the complete story.

